Inovio Pharmaceuticals, Inc. (INO) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.72
Day's range
$1.78

Inovio Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 02/17/2026 9.85 M $17.13 M   756,753.50% 18.87%
VANGUARD GROUP INC 01/29/2026 3.32 M $5.77 M   22.22% 6.36%
JANUS HENDERSON GROUP PLC 02/17/2026 3.31 M $5.77 M   1.29% 6.34%
ADAGE CAPITAL PARTNERS GP, L.L.C. 02/17/2026 2.55 M $4.44 M   -25.52% 4.89%
BOXER CAPITAL MANAGEMENT, LLC 02/17/2026 2.42 M $4.21 M   5.22% 4.64%
D. E. SHAW & CO., INC. 02/17/2026 2.23 M $3.88 M   176.64% 4.28%
ADAR1 CAPITAL MANAGEMENT, LLC 02/18/2026 1.49 M $2.58 M   100.00% 2.85%
MILLENNIUM MANAGEMENT LLC 02/17/2026 1.40 M $2.44 M   -28.85% 2.69%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 769.36 K $1.34 M   40.72% 1.47%
BLACKROCK, INC. 02/12/2026 617.87 K $1.08 M   23.72% 1.18%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 553.16 K $962.51 K   -32.24% 1.06%
DIADEMA PARTNERS LP 02/17/2026 533.68 K $928.61 K   100.00% 1.02%
GSA CAPITAL PARTNERS LLP 02/06/2026 459.83 K $800.00 K   3.77% 0.88%
CITADEL ADVISORS LLC 02/17/2026 384.20 K $668.51 K   218.84% 0.74%
TWO SIGMA INVESTMENTS, LP 02/17/2026 322.74 K $561.57 K   10.98% 0.62%
NORTHERN TRUST CORP 02/17/2026 299.98 K $521.97 K   25.79% 0.58%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 250.95 K $436.65 K   390.31% 0.48%
683 CAPITAL MANAGEMENT, LLC 02/17/2026 248.79 K $432.90 K   100.00% 0.48%
STATE STREET CORP 02/13/2026 247.41 K $430.49 K   32.87% 0.47%
OMERS ADMINISTRATION CORP 02/13/2026 223.00 K $388.02 K   100.00% 0.43%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 02/17/2026 173.00 K $301.02 K   100.00% 0.33%
UBS GROUP AG 01/29/2026 170.58 K $296.81 K   -41.79% 0.33%
XTX TOPCO LTD 02/17/2026 167.04 K $290.64 K   -20.67% 0.32%
PERSISTENT ASSET PARTNERS LTD 02/17/2026 142.16 K $247.37 K   100.00% 0.27%
JACOBS LEVY EQUITY MANAGEMENT, INC 02/13/2026 130.79 K $227.58 K   640.07% 0.25%
QUBE RESEARCH & TECHNOLOGIES LTD 02/17/2026 115.47 K $200.92 K   244.73% 0.22%
MORGAN STANLEY 02/13/2026 105.83 K $184.14 K   -86.55% 0.20%
DIADEMA PARTNERS LP 02/17/2026 100.00 K $174.00 K   100.00% 0.19%
MARSHALL WACE, LLP 02/13/2026 82.33 K $143.26 K   100.00% 0.16%
ADAR1 CAPITAL MANAGEMENT, LLC 02/18/2026 75.50 K $131.37 K   100.00% 0.14%
TWO SIGMA ADVISERS, LP 02/17/2026 73.70 K $128.24 K   -32.20% 0.14%
GREEN ALPHA ADVISORS, LLC 01/07/2026 72.10 K $125.45 K   49.92% 0.14%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 71.30 K $124.06 K   -59.81% 0.14%
BANK OF AMERICA CORP /DE/ 02/17/2026 65.79 K $114.47 K   -89.66% 0.13%
JANE STREET GROUP, LLC 02/12/2026 58.39 K $101.60 K   81.86% 0.11%
HUDSON BAY CAPITAL MANAGEMENT LP 02/13/2026 50.68 K $88.18 K   100.00% 0.10%
CIBC PRIVATE WEALTH GROUP, LLC 02/12/2026 50.00 K $87.00 K   357,042.86% 0.10%
CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD 03/04/2026 48.95 K $85.17 K   1,929.35% 0.09%
CITADEL ADVISORS LLC 02/17/2026 44.90 K $78.13 K   304.50% 0.09%
VIRTU FINANCIAL LLC 02/23/2026 44.04 K $77.00 K   100.00% 0.08%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 40.80 K $70.99 K   78.95% 0.08%
QUADRATURE CAPITAL LTD 02/17/2026 37.22 K $64.77 K   0.29% 0.07%
BAADER BANK AKTIENGESELLSCHAFT 02/05/2026 36.77 K $39.45 K   100.00% 0.07%
CONCURRENT INVESTMENT ADVISORS, LLC 01/29/2026 36.01 K $62.66 K   -35.71% 0.07%
LIGHTHOUSE INVESTMENT PARTNERS, LLC 02/17/2026 30.60 K $53.24 K   100.00% 0.06%
WOLVERINE ASSET MANAGEMENT LLC 02/02/2026 30.50 K $53.07 K   100.00% 0.06%
GOLDMAN SACHS GROUP INC 03/25/2026 27.29 K $47.48 K   -49.19% 0.05%
GREENWICH WEALTH MANAGEMENT LLC 02/10/2026 24.00 K $42.00 K   17.65% 0.05%
LPL FINANCIAL LLC 02/11/2026 18.61 K $32.39 K   -28.40% 0.04%
PRIME CAPITAL INVESTMENT ADVISORS, LLC 01/21/2026 18.03 K $31.36 K   -2.32% 0.03%

Inovio Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 186 institutional investors and hedge funds held shares of Inovio Pharmaceuticals Inc. The most heavily invested institutionals were:

VANGUARD FIDUCIARY TRUST CO: 392,066

GSA CAPITAL PARTNERS LLP: 265,075

UBS Group AG: 249,650

Persistent Asset Partners Ltd: 142,164

Green Alpha Advisors, LLC: 65,580

IMC-Chicago, LLC: 37,889

63.31% of Inovio Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 42.57 M shares in the last 24 months. This purchase volume represents approximately $73.64 M in transactions.